There are two different approaches to Nanotechnology in Drug Delivery, making drug crystals smaller to increase solubility and bioavailability, or using some form of carrier to deliver them in a more effective manner.
If we look at the total market size in 2021, it is a 60/40 split in favour of drug nano crystals although we feel that developing new delivery mechanisms may allow more value to be created.
The best performing nano carriers are shaping up to be:
- Liposomes (28%);
- Gold Nanocarriers (17%);
- Dendrimers (17%);
- Micelles (11%);
- Polymer-based Nanocarriers (5%);
- Nanoshells (2%);
- Ceramic Nanocarriers (<1%);
- Calcium phosphate Nanocarriers (<1%).